buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) Cited in 26 publications The glutathione synthesis inhibitor buthionine
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Iron based metal organic framework co loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo ferrotherapy via sustainable glutathione elimination Journal of Nanobiotechnology Springer Nature Link Lowering glutathione level by buthionine sulfoximine enhances in vivo photodynamic therapy using chlorin e6 loaded nanoparticles ScienceDirect Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




